Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: A systematic review

Journal of Asthma and Allergy

Volumn , Issue 2, 2009, Pages 9-16

  Di Lorenzo, Gabriele ^a,b   D'Alcamo, Alberto ^a   Rizzo, Manfredi ^a   Leto Barone, Maria Stefania ^a   Lo Bianco, Claudia ^a   Ditta, Vito ^a   Politi, Donatella ^a   Castello, Francesco ^a   Pepe, Ilenia ^a   Di Fede, Gaetana ^a   Rini, Giovambattista ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Dipartimento di Medicina Clinica e delle Patologie Emergenti   (Italy)

Author keywords

Antihistamine; Chronic idiopathic urticaria; Leukotriene receptor antagonists; Montelukast; Zafirlukast

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CETIRIZINE; CORTICOSTEROID; CYPROHEPTADINE; DESLORATADINE; DOXEPIN; FEXOFENADINE; FOOD ADDITIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MONTELUKAST; PLACEBO; PRANLUKAST; SALAZOSULFAPYRIDINE; THYROXINE; ZAFIRLUKAST; ZILEUTON;

ALLERGIC URTICARIA; APPLICATION SITE URTICARIA; CHRONIC URTICARIA; CLINICAL TRIAL; COLD URTICARIA; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DERMOGRAPHISM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENTIATION; FOOD ALLERGY; HUMAN; MONOTHERAPY; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; URTICARIA;

EID: 77953391610     PISSN: None     EISSN: 11786965     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664-672.
2. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002;346:175-179.
3. Grattan CE. The urticaria spectrum: recognition of clinical patterns can help management. Clin Exp Dermatol. 2004;29:217-221.
4. Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol. 2008;100:291-297.
5. Grattan CE, Boon AP, Eady RA, Winkelmann RK. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol. 1990;93:198-204.
6. Di Lorenzo G, Pacor ML, Vignola AM, et al. Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients. Allergy. 2002;57:1180-1186.
7. Di Lorenzo G, Pacor ML, Mansueto P, et al. Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. Int Arch Allergy Immunol. 2005;138:235-242. (Pubitemid 41540682)
8. Goldsobel AB, Rohr AS, Siegel SC, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1986;78:867-873. (Pubitemid 17194639)
9. Wanderer AA, St Pierre JP, Ellis EF. Primary acquired cold urticaria: double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol. 1977;113:1375-1377.
10. Kamide R, Niimura M, Ueda H, et al. Clinical evaluation of ketotifen for chronic urticaria: multicenter double-blind comparative study with clemastine. Ann Allergy. 1989;62:322-325. (Pubitemid 19116405)
11. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404-407.
12. Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy. 2006;61:321-331.
13. Zuberbier T, Munzberger C, Haustein U, et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology. 1996;193:324-327. (Pubitemid 27007577)
14. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114:465-474.
15. Engler RJ, Squire E, Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol. 1995;74:155-159.
16. Gaig P, Garcia-Ortega P, Enrique E, Richart C. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity. J Invest Allergy Clin Immunol. 2000;10:342-345 (Pubitemid 32113028)
17. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. 2000;143:365-372.
18. Bingham III CO. Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease. Curr Allergy Asthma Rep. 2008;8:278-287.
19. Di Lorenzo G, Pacor ML, Mansueto P, et al. Is there a role for antileukotrienes in urticaria? Clin Exp Dermatol. 2006;31:327-334.
20. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318:593-596.
21. Maxwell DL, Atkinson BA, Spur BW, Lessof MH, Lee TH. Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol. 1990;86:759-765.
22. Wedi B, Novacovich V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression: inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol. 2000;105:552-560. (Pubitemid 30169915)
23. Bisgaard H. Vascular effects of leukotriene D4 in human skin. J Invest Dermatol. 1987;88:109-114. (Pubitemid 17008986)
24. Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol. 1998;102:876-877. (Pubitemid 28543542)
25. Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol. 2000;85:156-157. (Pubitemid 30659542)
26. Tedeschi A, Suli C, Lorini M, Airaghi L. Successful treatment of chronic urticaria. Allergy. 2000;55:1097-1098.
27. Hani N, Hartmann K, Casper C, et al. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast. Acta Derm Venereol. 2000;80:229. (Pubitemid 30690596)
28. Bonadonna P, Lombardi C, Senna G, Canonica GW, Passalacqua G. Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol. 2003;49:714-716. (Pubitemid 37210290)
29. Berkun Y, Shalit M. Successful treatment of delayed pressure urticaria with montelukast. Allergy. 2000;55: 203-204.
30. Spector S, Tan RA. Antileukotrienes in chronic urticaria. J Allergy Clin Immunol. 1998;101:572.
31. Ohnishi-Inoue Y, Mitsuya K, Horio T. Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist. Br J Dermatol. 1998;138:483-485. (Pubitemid 28145519)
32. Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol. 2003;112:212-213. (Pubitemid 36819832)
33. Norris JG, Sullivan TJ. Leukotrienes and cytokines in steroid dependent chronic urticaria. J Allergy Clin Immunol. 1998;101:S128.
34. Asero R, Tedeschi A, Lorini M. Leukotriene receptor antagonists in chronic urticaria. Allergy. 2001;56:456-457.
35. Chu TJ, Warren MS. Zafirlukast (ACCOLATE-) in the treatment of chronic idiopathic urticaria - a case series. J Allergy Clin Immunol. 1998;101:S155.
36. Bensch GW, Borish L. Leukotriene receptor antagonists in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999;103:S154.
37. Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol. 2001;137:99-100. (Pubitemid 32096375)
38. Serrano C, Valero A, Picado C. Usefulness of montelukast to prevent adverse reactions to COX-2 selective inhibitors: a case report. J Investig Allergol Clin Immunol. 2005;15:156-157. (Pubitemid 41020180)
39. Goel A, Prasad D. Oral monteleukast in urticaria induced by nonsteroidal anti-inflammatory drugs. J Eur Acad Dermatol Venereol. 2007;21:1275-1276. (Pubitemid 47423432)
40. Godse KV. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol. 2006;72:312-314.
41. Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy. 2001;31:1607-1614. (Pubitemid 32939469)
42. Perez C, Sanchez-Borges M, Capriles E. Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol. 2001;108:1060-1061. (Pubitemid 34000450)
43. Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol. 2004;113:134-140. (Pubitemid 38096173)
44. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol. 2002;110:484-488.
45. Reimers A, Pichler C, Helbling A, Pichler WJ, Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy. 2002;32:1763-1768. (Pubitemid 35463863)
46. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy. 2004;34:1401-1407. (Pubitemid 39233695)
47. Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol. 2004;114:619-625. (Pubitemid 39194938)